Claritas Pharmaceuticals, Inc.

TSXV:CLAS.H Stock Report

Market Cap: CA$944.7k

Claritas Pharmaceuticals Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Bob Farrell

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure8yrs
CEO ownershipn/a
Management average tenure7.5yrs
Board average tenure6.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Bob Farrell's remuneration changed compared to Claritas Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2021n/an/a

US$2m

Jun 30 2021n/an/a

US$2m

Mar 31 2021n/an/a

-US$12m

Dec 31 2020US$300kUS$300k

US$4m

Sep 30 2020n/an/a

-US$7m

Jun 30 2020n/an/a

-US$8m

Mar 31 2020n/an/a

-US$875k

Dec 31 2019US$300kUS$300k

-US$21m

Sep 30 2019n/an/a

-US$12m

Jun 30 2019n/an/a

-US$9m

Mar 31 2019n/an/a

US$2m

Dec 31 2018US$300kUS$300k

US$7m

Sep 30 2018n/an/a

-US$21m

Jun 30 2018n/an/a

-US$24m

Mar 31 2018n/an/a

-US$32m

Dec 31 2017US$300kUS$300k

-US$32m

Compensation vs Market: Insufficient data to establish whether Bob's total compensation is reasonable compared to companies of similar size in the Canadian market.

Compensation vs Earnings: Insufficient data to compare Bob's compensation with company performance.

CEO

Bob Farrell

8yrs

Tenure

US$300,000

Compensation

Mr. Robert Farrell, also known as Bob, J.D., serves as the President of Claritas Pharmaceuticals, Inc. (formerly Kalytera Therapeutics, Inc.) and has been its Chief Executive Officer since October 10, 2017...

Leadership Team

NamePositionTenureCompensationOwnership
Robert Farrell
Chairman8yrsUS$300.00kno data
Victoria Rudman
Interim CFO9.3yrsUS$75.00kno data
Seth Yakatan
Co-Founderno dataUS$22.50kno data
Stuart Silverman
Co-Chair of Scientific Advisory Board and Vice President of Medical Affairsno datano datano data
Sari Prutchi-Sagiv
Chief Scientific Officer7.1yrsUS$212.00kno data
Moshe Yeshurun
Chief Medical Officer7.1yrsUS$162.00kno data
Amos Rosenthal
Head of Chemistryno datano datano data

7.5yrs

Average Tenure

56yo

Average Age

Experienced Management: CLAS.H's management team is seasoned and experienced (7.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Robert Farrell
Chairman7.6yrsUS$300.00kno data
Stuart Silverman
Co-Chair of Scientific Advisory Board and Vice President of Medical Affairs8.8yrsno datano data
Robert Langer
Member of Scientific Advisory Board8.1yrsno datano data
Joseph Tam
Member of Scientific Advisory Boardno datano datano data
Yanekl Gabet
Member of Scientific Advisory Boardno datano datano data
Deborah Kado
Member of Scientific Advisory Boardno datano datano data
Yong-Hui Jiang
Member of Scientific Advisory Boardno datano datano data
Joseph Lynch
Member of Strategic & Scientific Advisory Board6.2yrsno datano data
Li Zhang
Member of Strategic & Scientific Advisory Board6.2yrsno datano data
Hanns Zeilhofer
Member of Strategic & Scientific Advisory Board6.2yrsno datano data
Salvatore Cuzzocrea
Independent Director3.3yrsno datano data
Perenlei Enkhbaatar
Independent Director3.3yrsno datano data

6.2yrs

Average Tenure

Experienced Board: CLAS.H's board of directors are considered experienced (6.2 years average tenure).